Elon Musk recently suggested that the future of medicine could become digital. His argument is fascinating: instead of discovering drugs through years of trial and error, we may increasingly design biological instructions using synthetic RNA. In other words, medicine could move from finding molecules that happen to work toward programming cells to perform specific functions. And this idea is not pure science fiction. We already have technologies that can: - Use mRNA to instruct cells to produce specific proteins. - Use siRNA to silence disease-related gene expression. - Edit DNA using CRISPR technologies. - Use AI to help design proteins and identify potential drug candidates. But here is where things get interesting. A computer program runs according to defined instructions. A living cell operates within an incredibly complex biological environment. Writing an RNA sequence is one thing. Delivering it to the right cells, controlling its activity, avoiding unwanted immune responses, and proving long-term safety are entirely different challenges. Still, imagine what could happen if AI could analyze a patient's biology, design a therapeutic molecule, test it in automated laboratories, learn from the results, and continuously improve the next version. We might eventually move from treating diseases with standardized drugs toward designing therapies around individual biological problems. This could fundamentally change pharmaceutical research. But I have a bigger question: **If cells become programmable, will medicine eventually evolve from treating diseases to engineering biological function itself?** And what will be the biggest obstacle: understanding biology, designing the right molecules, delivering them safely, or proving they actually work? I'd love to hear perspectives from scientists, biotech professionals, and AI researchers. #AI #alsesAI #www.alsesai.com